Skip to main content

Biomerica, Inc. (BMRA)

NASDAQ: BMRA · Delayed Price · USD
5.12
-0.01 (-0.20%)
After-hours:Sep 24, 2021 4:17 PM EDT
5.13
0.50 (10.80%)
At close: Sep 24, 4:00 PM
Market Cap57.92M
Revenue (ttm)7.20M
Net Income (ttm)-6.47M
Shares Out12.51M
EPS (ttm)-0.54
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume220,342
Open4.57
Previous Close4.63
Day's Range4.57 - 5.17
52-Week Range3.30 - 8.15
Beta-0.68
AnalystsStrong Buy
Price Target12.00 (+133.9%)
Est. Earnings DateOct 15, 2021

About BMRA

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely ...

IndustryHealth Care Equipment & Supplies
Founded1971
Employees66
Stock ExchangeNASDAQ
Ticker SymbolBMRA
Full Company Profile

Financial Performance

In 2021, Biomerica's revenue was $7.20 million, an increase of 7.57% compared to the previous year's $6.69 million. Losses were -$6.47 million, 176.6% more than in 2020.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for Biomerica stock is "Strong Buy." The 12-month stock price forecast is 12.00, which is an increase of 133.92% from the latest price.

Price Target
$12.00
(133.92% upside)
Analyst Consensus: Strong Buy

News

Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrom...

IRVINE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced it expects final patient enrollment in its endpoint clinical trial for its InFoods® diagnostic-guided ther...

3 weeks ago - GlobeNewsWire

Biomerica Reports Fiscal 2021 Year End Results

IRVINE, Calif., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2021 financial results. During...

3 weeks ago - GlobeNewsWire

Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression

IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has issued a notice of allowance for Biomerica's first patent pertaining t...

1 month ago - GlobeNewsWire

Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test

IRVINE, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced the launch of their new website for their EZ Detect™ Colon Disease Test product at https://ezdetect.com. T...

1 month ago - GlobeNewsWire

Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori...

IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribut...

3 months ago - GlobeNewsWire

Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testi...

IRVINE, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today announced that the Mexican Patent Office has issued a notice of allowance for Biomerica's patent application pertai...

3 months ago - GlobeNewsWire

Biomerica to Participate in Upcoming Investor Conferences

IRVINE, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming investor c...

3 months ago - GlobeNewsWire

Biomerica's Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab

IRVINE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, announced that its new COVID-19 Antigen Rapid Test can now be performed w...

4 months ago - GlobeNewsWire

Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020

IRVINE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced its fiscal third quarter 2021 financial results for the...

5 months ago - GlobeNewsWire

Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update

IRVINE, Calif., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced financial results for its second quarter of fiscal year ...

8 months ago - GlobeNewsWire

Biomerica News: 10 Things for Potential BMRA Stock Investors to Know Today

Biomerica (BMRA) news for Tuesday concerning its rapid test for the novel coronavirus coming to new countries has BMRA stock on the rise. The post Biomerica News: 10 Things for Potential BMRA Stock Inve...

8 months ago - InvestorPlace

Biomerica's Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark

IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced it has received CE Mark for its new COVID-19 Rapid Antig...

8 months ago - GlobeNewsWire

Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment

IRVINE, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced it is nearing completion of patient enrollment in the en...

9 months ago - GlobeNewsWire

Biomerica Reports Fiscal 2021 1st Quarter Financial Results

IRVINE, Calif., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported financial results for the fiscal quarter ended August 31,...

11 months ago - GlobeNewsWire

Biomerica Reports Fiscal Year End May 31, 2020 Financial Results

IRVINE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the fiscal year ended May 31, 2020 were ...

1 year ago - GlobeNewsWire

Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to t...

IRVINE, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced today the retirement of Janet Moore, the Company’s Chief Financial Officer. After many years of dedicate...

1 year ago - GlobeNewsWire

Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irrita...

IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for Biomerica’s seco...

1 year ago - GlobeNewsWire

Biomerica Announces Filing of New Three Year Shelf Registration Statement

IRVINE, Calif., July 22, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has filed a new three year shelf registration statement on Form S-3 with the United States Secur...

1 year ago - GlobeNewsWire

The 7 Best Cheap Stocks Under $10 Right Now

Here are seven cheap stocks to buy in the second half of the year. They come with risk, but are likely to offer head-turning reward potential, too.

Other symbols:AEGFUVGAIAGTXHMYNMR
1 year ago - InvestorPlace

Biomerica's COVID-19 Test Ignite The Market

Biomerica's COVID-19 Test Ignite The Market

1 year ago - Seeking Alpha

The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") ...

IRVINE, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced it has signed a definitive agreement with the University of Texas Health Science Center at Houston (“UTH...

1 year ago - GlobeNewsWire

Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19

IRVINE, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today they have submitted to the FDA an EUA application for an ELISA lab-based serology blood test for the det...

1 year ago - GlobeNewsWire

Mayo Clinic joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy clinical trial

IRVINE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced they have signed definitive agreements with Mayo Clinic to join the clinical trial for Biomerica’s new I...

1 year ago - GlobeNewsWire

Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands Internatio...

IRVINE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced it has received a CE mark and launched a new high-volume production version of its COVID-19 IgG/IgM Rapid...

1 year ago - GlobeNewsWire

Why Biomerica's Stock Is Trading Higher Today

Biomerica, Inc. (NASDAQ: BMRA) shares are trading higher after the company announced it has signed two definitive agreements with Mount Sinai Medical School in NY to scale-up a laboratory version serolo...

1 year ago - Benzinga